PNC Financial Services Group
NPCE icon

PNC Financial Services Group’s Neuropace NPCE Stock Holding History

PNC Financial Services Group’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159 Buy
+10
New +$161 ﹤0.01% 5119
2025
Q3 		– Sell
-65
Closed -$724 – 5187
2025
Q2 		$724 Buy
+65
New +$813 ﹤0.01% 4620

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

PNC Financial Services Group's NPCE Position: Q2 2026 in Review

PNC Financial Services Group opened a new position in Neuropace (NPCE) in Q2 2026: 10 shares worth $159. The stake represents ﹤0.01% of the portfolio and ranks #5119 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in NPCE as recently as Q2 2025.

PNC Financial Services Group first reported a position in NPCE in Q2 2025 and has held it in 2 quarters since. The position peaked at $724 in Q2 2025. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • PNC Financial Services Group held 10 shares of Neuropace worth $159 as of Q2 2026.
  • Neuropace was a new PNC Financial Services Group position in Q2 2026.
  • Neuropace made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5119 holding.
  • PNC Financial Services Group first reported a position in Neuropace in Q2 2025 and has held it in 2 quarters since.
  • PNC Financial Services Group's Neuropace position peaked at $724 in Q2 2025.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.